HemaSphere (Oct 2022)

P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma

  • John Radford,
  • Toyin Adedayo,
  • Arzhang Ardavan,
  • Sally F. Barrington,
  • Leanne Berkahn,
  • Stephane Chauvie,
  • Laura Clifton-Hadley,
  • Graham P. Collins,
  • Michael Crump,
  • David Cutter,
  • Darren Edwards,
  • Martin Hutchings,
  • Tim Illidge,
  • Amy A. Kirkwood,
  • Kim Linton,
  • Craig H. Moskowitz,
  • Pip Patrick,
  • Beth Phillips,
  • Lois Shepherd,
  • Sanne Tonino,
  • Judith Trotman,
  • Joanna Williams,
  • Nicole Wong Doo

DOI
https://doi.org/10.1097/01.HS9.0000890668.27643.97
Journal volume & issue
Vol. 6
pp. 12 – 13

Abstract

Read online

No abstracts available.